Cargando…
(18)F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study
Objectives: To evaluate the ability of (18)F-labeled fluoro-2-deoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) to predict survivorship of patients with bladder cancer (BC) and/or upper urinary tract carcinoma (UUTC). Materials: Data from patients who underwent FDG PET...
Autores principales: | Zattoni, Fabio, Incerti, Elena, Dal Moro, Fabrizio, Moschini, Marco, Castellucci, Paolo, Panareo, Stefano, Picchio, Maria, Fallanca, Federico, Briganti, Alberto, Gallina, Andrea, Fanti, Stefano, Schiavina, Riccardo, Brunocilla, Eugenio, Rambaldi, Ilaria, Lowe, Val, Karnes, R. Jeffrey, Evangelista, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562413/ https://www.ncbi.nlm.nih.gov/pubmed/31137599 http://dx.doi.org/10.3390/cancers11050700 |
Ejemplares similares
-
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with (68)Ga-PSMA PET/CT Features in Primary Staging
por: Vetrone, Luigia, et al.
Publicado: (2023) -
Dynamic FDG PET/CT on bladder paraganglioma: A case report
por: Taninokuchi Tomassoni, Makoto, et al.
Publicado: (2022) -
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence
por: Bianchi, Lorenzo, et al.
Publicado: (2022) -
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2020) -
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment
por: Bianchi, Lorenzo, et al.
Publicado: (2023)